Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer

BACKGROUND: Despite the well-known role of immunoscore, as a prognostic tool, that appeared to be superior to tumor–node–metastasis (TNM) staging system, no prognostic scoring system based on immunohistochemistry (IHC) staining digital image analysis has been established in non-small cell lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lan, Huang, Yanqi, Chen, Xin, Huang, Xiaomei, Wang, Huihui, Zhang, Yuan, Liang, Changhong, Li, Zhenhui, Yan, Lixu, Liu, Zaiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983932/
https://www.ncbi.nlm.nih.gov/pubmed/35401554
http://dx.doi.org/10.3389/fimmu.2022.835630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983932/
https://www.ncbi.nlm.nih.gov/pubmed/35401554
http://dx.doi.org/10.3389/fimmu.2022.835630

Ejemplares similares